Fig. 1From: Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reportsLab trends in relation to eculizumab initiation for both patients. a Trend of platelet count (B/L) and serum creatinine (mg/dL) during case 1 hospitalization, with note of day of eculizumab initiation. On eculizumab initiation, platelet count was 27Â B/L and creatinine was 5.44Â mg/dL. b Trend of platelet count (B/L) and serum creatinine (mg/dL) during case 2 hospitalization, with note of day of eculizumab initiation. On eculizumab initiation, platelet count was 84Â B/L and creatinine was 4.25Â mg/dLBack to article page